Vyvanse (2015-12-23)

Starting date:
December 23, 2015
Posting date:
December 31, 2015
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-56514

Affected Products

Vyvanse

Reason

Some labels were found missing on product bottles from these lots.

Depth of distribution

Wholesalers across Canada

Affected products

Vyvanse

DIN, NPN, DIN-HIM
DIN 02322951
Dosage form

Capsule

Strength

Lisdexamfetamine Dimesylate 30mg

Lot or serial number
  • AD8671B
  • AD8672B
Companies
Recalling Firm
Shire Pharma Canada ULC
2250 Alfred-Nobel Blvd, suite 500
Saint-Laurent
H4S 2C9
Quebec
CANADA
Marketing Authorization Holder
Shire Pharma Canada ULC
2250 Alfred-Nobel Blvd, suite 500
Saint-Laurent
H4S 2C9
Quebec
CANADA